TPO基因及其应用研究

邢岩

TPO基因及其应用研究

邢岩

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 6: (248-252)

引用本文:

Citation:

TPO基因及其应用研究

邢岩

610041 成都, 四川大学华西医院核医学科

作者简介: 邢岩(1977-),女,四川绵阳人,硕士研究生,主要从事分子核医学方面的研究。;

基金项目:
国家自然科学基金资助项目(30170281)
中图分类号: R817.5;Q554⁺.6

The research and application of TPO's gene

XING Yan

Department of Nuclear Medicine, First Hospital of West China Medical Centre, Sichuan University, Chengdu 610041, China
CLC number: R817.5;Q554⁺.6

摘要: TPO(甲状腺过氧化物酶)是甲状腺细胞膜上的一种糖蛋白,是合成甲状腺激素的关键酶。深入研究其基因结构及转录调控对甲状腺疾病和放射性碘治疗具有重要意义。
- 甲状腺 /
- 过氧化物酶 /
- 放射性碘治疗
Abstract: Thyroperoxidase (TPO)is a glycosylated protein bound to the apical plasma membrane of thyrocytes.It is the key enzyme in the synthesis of thyroid hormones.Its gene structure and transcriptional regulation have been deeply studied.This article reviews the development of TPO's gene structure,function,transcriptional regulation,the relation-ship between TPO with thyroid diseases and radioactive iodide therapy.
- thyroid /
- peroxidase /
- radioactive iodide therapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Shioko K, Tomio K, Mcbride OW, et al. Human thyroid peroxidace:complete cDNA and protein sequende, chromosome mapping, and identification of two alternately spliced mRNAs[J]. Proc Natl Acad Sci USA, 1987, 84(16):5555-5559.
[2]	Niccoli P, Fayadat L, Panneels V, et al. Human thyroperoxidase in its alternatively spliced form (TPO2) is enzymatically inactive and exhibits changes in intracellular processing and trafficking[J]. J Biol Chem, 1997, 272(47):29487-29492.
[3]	Marc A, Gilbert V, Daniel C, et al. Functional study of the human thyroid perexidase gene promoter[J]. Eur J Biochem, 1992, 203(3) 467-473.
[4]	Lourdes O, Pedro AB, Mariastella Z, et al. The interaction between the forkhead thyroid tran-sciption factor TTF-2 and the constitutive factor CTF/NT-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription[J]. J Biol Chem, 1999, 274(21):15213-15221.
[5]	Mariastella Z, Helen FL, Dimitri P, et al. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters[J]. Mol Cell Biol, 1992, 12(9):4230-4241.
[6]	Rossana DL, Stefania M, Enrico Z, et al. Role for p300 in Pax8 induction of thyroperoxidase gene expression[J]. J Biol Chem, 2000, 275(44):34100-34105.
[7]	Claudio E, Stetania M, Adolfo S, et al. Pax8 activates the enhancer of the human thyroperoxi-dase gene[J]. Biochem J, 1998, 331(1):37-40.
[8]	Gerard CM, Lefort A, Christophe D, et al. Distinct transcriptional effects of cAMP on 2 thyroid specific genes:thyroperoxidase and thyroglobulin[J]. Horm Metab Res buppl, 1990, 23:38-43.
[9]	Penel C, Gruffat D, Alquier C, et al. Thyrotropin chronically regulates the pool of thyropero-xidase and its intra-cellular distribution:a quantitative confocal microscopic study[J]. J Cell Physiol, 1998, 174(2):160-169.
[10]	Napolitano G, Montani V, Giuliani C, et al. Transforming growth factor-betal down-regulation of major histo-compatibility complex class I in thyrocytes:coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors[J]. Mol Endocrinol, 2000, 14(4):486-505.
[11]	Miyazaki A, Shimura H, Endo T, et al. Tumor necrosis factor-alpha and interferon-gamma suppress both gene expression and deoxyribonucleic acid-binding of TTF-2 in FRTL-5 cells[J]. Endocrinology, 1999, 140(9):4214-4220.
[12]	Uyttersprot N, Pelgrims N, Carrasco N, et al. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid[J]. Mol Cell Endocrinol, 1997, 131(2):195-203.
[13]	Ortia L, Zannini M, Di-Lauro R, et al. Transcriptional contral of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor 1[J]. J Biol Chem, 1997, 272(37):23334-23339.
[14]	Da-Costa VM, Moreira DG, Rosenthal D, et al. Thyroid function and aging:gender-related differences[J]. J Endocrinol, 2001, 171(1):193-198.
[15]	Armengol MP, Juan M, Lucas MA, et al. Thyroid autoimmune disease:demon-stration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers[J]. Am J Pathol, 2001, 159(3):861-873.
[16]	Niedziela M, Korman E. Severe hypothyroidism due to autoimmune atrophic thyroiditis-predicted target height and a plausible mechanism for sexual precocity[J]. J Pediatr Endocrinol Metab, 2001, 14(7):901-907.
[17]	Deleu S, Allory Y, Radulescu A, et al. Characterization of autonomous thyroid adenoma:metabolism, gene expression, and pathology[J]. Thyroid, 2000, 10(2):131-140.
[18]	Ros P, Rossi DL, Acebron A, et al. Thyroid-specific gene expression in the multi-step process of thyroid careino-genesis[J]. Biochimie, 1999, 81(4):389-396.
[19]	Franke WG, Zophel K, Wunderlieh GR, et al. Thyropemxidase:a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study[J]. Cancer Detect Prey, 2000, 24(6):524-530.
[20]	Geraldo M, Maria J, Cecilia L, et al. Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene[J]. J Clin Endoerinol Metab, 1998, 83(11):4162-4166.
[21]	Haberkorn U, Altmann A, Jiang S, et al. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene[J]. Eur J Nucl Med, 2001, 28(5):633-638.
[22]	Huang M, Raj K, Takahiko K, et al. Ectopic expression of the thyroperoxidase gene aug-ments radioiodide uptake and retention mediated by the sodium iodide symporter in nonsmall cell lung cancer[J]. Cancer Gene Therapy, 2001, 8(8):612-618.
[23]	Boland A, Magnon C, Filetti S, et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers[J]. Thyroid, 2002, 12(1):19-26.

[1]	李倩 . 钠/碘转运体的临床实用价值. 国际放射医学核医学杂志, 2003, 27(2): 56-58,65.
[2]	张静 , 贾茜 , 赵傲梅 , 杨爱民 . 分化型甲状腺癌放射性碘治疗敏感性及其影响因素的研究进展. 国际放射医学核医学杂志, 2022, 46(4): 245-253. doi: 10.3760/cma.j.cn121381-202103030-00168
[3]	王玉华 , 李亚明 . 过量碘摄入对甲状腺功能影响的探讨. 国际放射医学核医学杂志, 2009, 33(4): 206-209. doi: 10.3760/cma.j.issn.1673-4114.2009.04.005
[4]	胡小春 , 蒋宁一 , 李敬彦 , 张弘 , 刘生 , 卢献平 , 梁九根 , 张占磊 . 硒对经¹³¹I治疗Graves病患者血清甲状腺过氧化物酶抗体水平的影响. 国际放射医学核医学杂志, 2015, 39(2): 140-143. doi: 10.3760/cma.j.issn.1673-4114.2015.02.008
[5]	闵锐 , 潘真 , 李雨 . 急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二. 国际放射医学核医学杂志, 2005, 29(6): 272-278.
[6]	王长修 . 碳酸锂在低摄¹³¹I率Graves病患者¹³¹I治疗中的应用价值. 国际放射医学核医学杂志, 2010, 34(2): 100-101. doi: 10.3760/cma.j.issn.1673-4114.2010.02.010
[7]	陈立波 . 钠/碘同向转运体与放射性碘治疗. 国际放射医学核医学杂志, 2001, 25(6): 258-261.
[8]	翟歌 , 李彪 . PET-CT全身显像甲状腺意外摄取¹⁸F-FDG的临床价值. 国际放射医学核医学杂志, 2009, 33(4): 235-237. doi: 10.3760/cma.j.issn.1673-4114.2009.04.013
[9]	柳卫 , 张满达 , 王铁生 . 钠/碘同向转运体. 国际放射医学核医学杂志, 2001, 25(2): 49-52.
[10]	李伟 , 龙晚生 , 张朝桐 , 胡茂清 , 梁启堂 , 赖婵 . Radimetrics系统在CT辐射剂量评估上的初步应用. 国际放射医学核医学杂志, 2017, 41(6): 401-406. doi: 10.3760/cma.j.issn.1673-4114.2017.06.005